As a known E3 ubiquitin ligase, the transient silencing of p53-induced RING-H2 protein (Pirh2) has been shown to reduce levels of pathological markers characteristic of AD, such as hyperphosphorylation of Tau protein and excessive accumulation of Aβ. Here, MAPT is linked to Alzheimer disease.